The title molecular salts, C 10 H 15 N 2 + ÁC 6 H 6 ClN 2 O 2 À , (I), and C 10 H 15 N 2 + Á-C 7 H 8 ClN 2 O 2 À , (II), consist of 4-phenylpiperazin-1-ium cations with a 6-chloro-5-ethyl-2,4-dioxopyrimidin-1-ide anion in (I) and a 6-chloro-5-isopropyl-2,4-dioxopyrimidin-1-ide anion in (II). Salt (I) crystallizes with two independent cations and anions in the asymmetric unit. In the crystal structures of both salts, the ions are linked via N-HÁ Á ÁO and N-HÁ Á ÁN hydrogen bonds, forming sheets which are parallel to (100) in (I) and to (001) in (II). In (I), the sheets are linked via C-HÁ Á ÁCl hydrogen bonds, forming a three-dimensional framework.
Chemical context
2,4-Dioxopyrimidine derivatives (uracils) and their related analogues are known for their diverse chemotherapeutic activities including anticancer activity (Ghoshal & Jacob, 1997; Spá čilová et al., 2007; Blokhina et al., 1972) , anti-HIV activity (Tanaka et al., 1995; El-Emam et al., 2004) and antibacterial activity (Al-Turkistani et al., 2011) . In addition, the piperazine nucleus constitutes the core pharmacophore of several biologically active compounds which display antiviral (Romero et al., 1994 (Romero et al., , 1996 , anticancer (Fytas et al., 2015; Kamal et al., 2015; Arnatt et al., 2014) , antitubercular and antibacterial (Nagesh et al., 2014; Peng et al., 2015; Kapić et al., 2011; Wang et al., 2014) and central nervous system activities (Bender et al., 2014; Bali et al., 2010) . ISSN 2056-9890 As a result of the relative acidity of 2,4-dioxopyrimidines (Kurinovich & Lee, 2002; Jang et al., 2001; Nguyen et al., 1998) , the title piperazinium salts were isolated as minor byproducts during the reaction of 1-phenylpiperazine with 5-alkyl-6-chlorouracils (Al-Turkistani et al., 2011) . In a continuation of our interest in the structures of piperazinium salts (Al-Omary et al., 2014), we report herein on the isolation and crystal structures of these two new piperazinium salts, (I) and (II).
Structural commentary
The molecular structures of the title salts (I) and (II) are illustrated in Figs. 1 and 2, respectively. Compound (I) crystallizes with two independent 4-phenylpiperazin-1-ium cations (A and B) and two independent 6-chloro-5-ethyl-2, 4-dioxopyrimidin-1-ide anions (C and D) in the asymmetric unit. In both compounds, the piperazine rings adopt a distorted chair conformation with a positively charged protonated N atom. In compound (I), the mean plane of the piperazine ring makes a dihedral angle of 34.8 (2) with the attached phenyl ring in cation A, and 39.7 (2) in cation B. The equivalent dihedral angle is 39.61 (9) in the cation of compound (II). In the uracil anions, the pyrimidine rings are almost planar with r.m.s. deviations of 0.008 Å in both anions (C and D) of compound (I), and 0.024 Å in compound (II).
Supramolecular features
In the crystal of (I), two tetranuclear units are formed, involving cation A and anion C, and cation B and anion D, via N-HÁ Á ÁO and C-HÁ Á ÁO hydrogen bonds. These units are linked via N-HÁ Á ÁN hydrogen bonds, forming separate A/B and C/D sheets parallel to the bc plane (Table 1 and Fig. 3 ). The sheets are linked via C-HÁ Á ÁCl hydrogen bonds, forming a three-dimensional framework ( Fig. 3 and Table 1 ).
In the crystal of (II), the cation and anion are linked by N-HÁ Á ÁO and C-HÁ Á ÁO hydrogen bonds, forming chains extending along the b-axis direction. The molecular structure of compound (II) , showing the atom labelling. Displacement ellipsoids are drawn at the 50% probability level. Table 1 Hydrogen-bond geometry (Å , ) for (I). 
Figure 3
The crystal packing of compound (I), viewed along the b axis, showing the most relevant hydrogen bonding (dashed lines; see Table 1 ).
Figure 1
The molecular structure of compound (I), showing the atom labelling. Displacement ellipsoids are drawn at the 50% probability level.
N-HÁ Á ÁN hydrogen bonds, forming sheets lying parallel to the ac plane (Table 2 and Fig. 4 ).
Database survey
A search of the Cambridge Structural Database (Version 5.36, last update November 2014; Groom & Allen, 2014 ) for the anion 6-chloro-5-ethyl-2,4-dioxopyrimidin-1-ide, present in compound (I), gave no hits, while for the anion 6-chloro-5-isopropyl-2,4-dioxopyrimidin-1-ide, present in compound (II), one hit was obtained, with the cation 4-(2-methoxyphenyl)piperazin-1-ium (Al-Omary et al., 2014).
Synthesis and crystallization
Compound (I): A mixture of 6-chloro-5-ethyluracil (349 mg, 2.0 mmol), 1-phenylpiperazine (325 mg, 2.0 mmol) and anhydrous potassium carbonate (276 mg, 2.0 mmol), in ethanol (8 ml), was heated under reflux for 6 h. On cooling, the precipitate, thus formed was separated by filtration to yield 306 mg (51%) of 5-ethyl-6-(4-phenyl-1-piperazinyl)uracil. The filtrate was concentrated by vacuum distillation to 5 ml and allowed to stand at room temperature overnight to yield compound (I) as colourless crystals (m. Table 2 Hydrogen-bond geometry (Å , ) for (II). 
Figure 4
The crystal packing of compound (II), viewed along the b axis, showing the most relevant hydrogen bonding (dashed lines; see Table 2 ). 44.18, 116.32, 119.62, 128.44, 108.88, 153.90, 155.94, , Compound (II): 6-Chloro-5-isopropyluracil (377 mg, 2.0 mmol), 1-phenylpiperazine (325 mg, 2.0 mmol) and anhydrous potassium carbonate (276 mg, 2.0 mmol), in ethanol (8 ml), was heated under reflux for 6 h. On cooling, the precipitate thus formed was separated by filtration to yield 566 mg (90%) of 5-isopropyl-6-(4-phenyl-1-piperazinyl)uracil. The filtrate was concentrated by vacuum distillation to 5 ml and allowed to stand at room temperature overnight to yield compound (II) as colourless crystals (m.p.: 473-475 K). 
Refinement
Crystal data, data collection and structure refinement details are summarized in Table 3 . The H atoms were included in calculated positions and treated as riding atoms: N-H = 0.86-0.90 Å , C-H = 0.95-1.00 Å with U iso (H) = 1.5U eq (C) for methyl H atoms and 1.2U eq (N,C) for other H atoms. For both compounds, data collection: CrysAlis PRO (Agilent, 2014 ); cell refinement: CrysAlis PRO (Agilent, 2014) ; data reduction: CrysAlis PRO (Agilent, 2014 ); program(s) used to solve structure: SIR2011 (Burla et al., 2012); program(s) used to refine structure: SHELXL2014 (Sheldrick, 2015) ; molecular graphics: Mercury (Macrae et al., 2008) ; software used to prepare material for publication: SHELXL2014 (Sheldrick, 2015) , PLATON (Spek, 2009) and publCIF (Westrip, 2010) . 1.436 (6) C24-H24B 0.9700 C4-C3
1.359 (6) C29-C30 1.383 (7) C2-C3
1.440 (6) C29-H29 0.9300 C20-C19
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